vs

Side-by-side financial comparison of Birkenstock Holding plc (BIRK) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $526.3M, roughly 1.4× Birkenstock Holding plc). Healthpeak Properties runs the higher net margin — 73.2% vs 19.3%, a 53.9% gap on every dollar of revenue. Over the past eight quarters, Birkenstock Holding plc's revenue compounded faster (26.8% CAGR vs 8.9%).

Birkenstock Holding plc is a German shoe manufacturer known for its sandals and other shoes notable for contoured cork footbeds (soles), made with layers of suede and jute, which conform to the shape of their wearers' feet. Founded in 1774 by Johann Adam Birkenstock and headquartered in Neustadt (Wied), Rhineland-Palatinate, Germany, the company's original purpose was to create shoes that support and contour the foot, compared to the flat soles of many shoes during that time. In 1896, the Fus...

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

BIRK vs DOC — Head-to-Head

Bigger by revenue
DOC
DOC
1.4× larger
DOC
$719.4M
$526.3M
BIRK
Higher net margin
DOC
DOC
53.9% more per $
DOC
73.2%
19.3%
BIRK
Faster 2-yr revenue CAGR
BIRK
BIRK
Annualised
BIRK
26.8%
8.9%
DOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BIRK
BIRK
DOC
DOC
Revenue
$526.3M
$719.4M
Net Profit
$101.4M
$114.0M
Gross Margin
62.8%
Operating Margin
23.0%
17.4%
Net Margin
19.3%
73.2%
Revenue YoY
3.1%
Net Profit YoY
2406.4%
EPS (diluted)
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIRK
BIRK
DOC
DOC
Q4 25
$719.4M
Q3 25
$526.3M
$705.9M
Q2 25
$685.8M
$694.3M
Q1 25
$620.3M
$702.9M
Q4 24
$390.7M
$698.0M
Q3 24
$455.8M
$700.4M
Q2 24
$609.9M
$695.5M
Q1 24
$519.7M
$606.6M
Net Profit
BIRK
BIRK
DOC
DOC
Q4 25
$114.0M
Q3 25
$101.4M
$-117.1M
Q2 25
$139.6M
$31.7M
Q1 25
$113.5M
$42.8M
Q4 24
$21.7M
$4.5M
Q3 24
$85.9M
Q2 24
$80.6M
$146.0M
Q1 24
$77.4M
$6.7M
Gross Margin
BIRK
BIRK
DOC
DOC
Q4 25
Q3 25
62.8%
58.6%
Q2 25
60.5%
60.2%
Q1 25
57.7%
61.1%
Q4 24
60.3%
60.3%
Q3 24
60.0%
Q2 24
59.5%
60.6%
Q1 24
56.3%
59.8%
Operating Margin
BIRK
BIRK
DOC
DOC
Q4 25
17.4%
Q3 25
23.0%
9.2%
Q2 25
31.2%
5.7%
Q1 25
30.5%
7.7%
Q4 24
17.7%
-2.2%
Q3 24
14.1%
Q2 24
27.5%
22.3%
Q1 24
27.5%
3.7%
Net Margin
BIRK
BIRK
DOC
DOC
Q4 25
73.2%
Q3 25
19.3%
-16.6%
Q2 25
20.3%
4.6%
Q1 25
18.3%
6.1%
Q4 24
5.6%
0.7%
Q3 24
12.3%
Q2 24
13.2%
21.0%
Q1 24
14.9%
1.1%
EPS (diluted)
BIRK
BIRK
DOC
DOC
Q4 25
$0.16
Q3 25
$-0.17
Q2 25
$0.05
Q1 25
$0.06
Q4 24
$0.02
Q3 24
$0.12
Q2 24
$0.21
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIRK
BIRK
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$355.4M
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$2.9B
$7.5B
Total Assets
$5.3B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIRK
BIRK
DOC
DOC
Q4 25
$467.5M
Q3 25
$355.4M
$91.0M
Q2 25
$282.8M
$89.4M
Q1 25
$254.2M
$70.6M
Q4 24
$322.5M
$119.8M
Q3 24
$384.3M
$180.4M
Q2 24
$436.7M
$106.9M
Q1 24
$189.8M
$101.8M
Total Debt
BIRK
BIRK
DOC
DOC
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Q1 24
$8.8B
Stockholders' Equity
BIRK
BIRK
DOC
DOC
Q4 25
$7.5B
Q3 25
$2.9B
$7.6B
Q2 25
$2.8B
$7.9B
Q1 25
$3.0B
$8.2B
Q4 24
$3.0B
$8.4B
Q3 24
$2.8B
$8.6B
Q2 24
$2.8B
$8.8B
Q1 24
$2.7B
$8.9B
Total Assets
BIRK
BIRK
DOC
DOC
Q4 25
$20.3B
Q3 25
$5.3B
$19.6B
Q2 25
$5.3B
$19.8B
Q1 25
$5.4B
$19.8B
Q4 24
$5.4B
$19.9B
Q3 24
$5.3B
$20.0B
Q2 24
$5.4B
$20.2B
Q1 24
$5.2B
$20.5B
Debt / Equity
BIRK
BIRK
DOC
DOC
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIRK
BIRK
DOC
DOC
Operating Cash FlowLast quarter
$415.0M
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
4.09×
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIRK
BIRK
DOC
DOC
Q4 25
$1.3B
Q3 25
$415.0M
$315.0M
Q2 25
$363.5M
Q1 25
$279.4M
Q4 24
$-12.6M
$1.1B
Q3 24
$463.0M
$318.2M
Q2 24
$316.2M
Q1 24
$152.6M
Free Cash Flow
BIRK
BIRK
DOC
DOC
Q4 25
$357.0M
Q3 25
Q2 25
Q1 25
Q4 24
$333.7M
Q3 24
Q2 24
Q1 24
FCF Margin
BIRK
BIRK
DOC
DOC
Q4 25
49.6%
Q3 25
Q2 25
Q1 25
Q4 24
47.8%
Q3 24
Q2 24
Q1 24
Capex Intensity
BIRK
BIRK
DOC
DOC
Q4 25
124.4%
Q3 25
Q2 25
Q1 25
Q4 24
105.6%
Q3 24
Q2 24
Q1 24
Cash Conversion
BIRK
BIRK
DOC
DOC
Q4 25
10.99×
Q3 25
4.09×
Q2 25
11.48×
Q1 25
6.52×
Q4 24
-0.58×
235.43×
Q3 24
3.71×
Q2 24
2.17×
Q1 24
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons